Search
GeneDx Holdings Corp
WGSAdd to Watchlist
85.200USD
-5.600-6.17%
Close 09-23 16:00（ET）
2.53BMarket Cap
LossP/E TTM
GeneDx Holdings Corp (WGS) Revenue Performance
Updated: Jun 30, 2026By Business
Revenue
Proportion
Annual
Annual
Quarterly
Patients with third party insurance
Institutional customers
Other
Self pay patients
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
Patients with third party insurance
345.24M(80.75%)
234.70M(76.84%)
134.49M(66.39%)
173.62M(73.98%)
169.58M(79.92%)
138.15M(77.04%)
169.54M(86.42%)
112.54M(84.40%)
Institutional customers
70.07M(16.39%)
65.11M(21.32%)
59.50M(29.37%)
46.12M(19.65%)
31.72M(14.95%)
35.20M(19.63%)
20.89M(10.65%)
19.61M(14.70%)
Other
10.87M(2.54%)
3.29M(1.08%)
6.91M(3.41%)
7.36M(3.14%)
7.09M(3.34%)
3.97M(2.21%)
4.51M(2.30%)
371.00K(0.28%)
Self pay patients
1.36M(0.32%)
2.34M(0.77%)
1.67M(0.82%)
7.59M(3.23%)
3.81M(1.79%)
2.00M(1.11%)
1.24M(0.63%)
822.00K(0.62%)